Current Research
I am currently in the final (I hope) stages of working on a book
tentatively called Populations, Population Health, and the Law. The book explores the role
of public health in the law and seeks to develop an approach to legal analysis that I call
population-based legal analysis. Because the book applies that approach to many areas of the
law, I've had to learn numerous doctrines and areas of the law. Right now, as I'm working on
the final chapter, I'm looking at the relationship between public health and international
human rights law, a subject that is of course quite central to much of the work that is going
on in the law school, but relatively new to me.
Most Interesting Case
Bragdon v. Abbott. About a decade ago, I had the amazing opportunity
to work with Ben Klein, a very gifted lawyer at Gay & Lesbian Advocates & Defenders (GLAD),
on a case brought under the Americans with Disabilities Act (ADA) by a woman who was
discriminated against by a dentist because she was HIV positive. Lo and behold, the case
went to the US Supreme Court and became that Court's first case defining the ADA as well as
the Court's first case deciding the rights of people who are HIV-positive. Remarkably, the
case raised all of the issues and concerns that I have thought about throughout my career
— discrimination, health care access, public health protection and the rights of people
with disabilities. Working on the case with Ben was a challenging, stimulating and
exciting experience. And, thankfully, we won!
Recent Publications
My most recent article is "A New Era of Unapproved Drugs: The Case of
Abigail Alliance v. Von Esenbach," in 297 Journal of the American Medical Association 205
(2006), with Peter Jacobson. This article reports on and criticizes a quite-remarkable
decision of the United States Court of Appeals for the District of Columbia last June, which
found that terminally ill patients had a fundamental constitutional right to use drugs that
had completed the first stage of the FDA approval process but had not yet been licensed.
While the article was in publication, right before Thanksgiving, the Court of Appeals
vacated the decision and ordered a rehearing en banc. Then, a short time later, the FDA
proposed new regulations designed to make unapproved drugs more accessible. As you can
imagine, my co-author, Professor Peter Jacobson, and I were getting tired of writing last
minute revisions! But all of these developments kept the topic interesting and notable. The
full Court of Appeals is going to rehear the case shortly; so the case — which goes to
the heart of the FDA's authority to regulate drugs for safety and efficacy — remains
very much alive.
Also in the past few months, several other articles and chapters that I have written over the
past year have been published. "Terri and Katrina: A Population-Based Perspective on the
Constitutional Right to Reject Treatment," in 15 Temple Political and Civil Rights Law Review
395 (2006), looks at the so-called right to die and the controversy surrounding the Terri
Schaivo case from a public health perspective. "Pharmaceuticals, Public Health and the Law:
A Public Health Perspective," is a chapter in a newly published book, The Power of the
Pill, edited by Northeastern Philosophy Professor Patricia Illingworth and University of
Toronoto Professor Jillian Cohen. In the chapter, I discuss some of the ways in which
pharmaceuticals have characteristics of public goods. In the introduction to the 2d edition
of Law and Public Health Practice (Richard Goodman, et. al., eds.), I discuss the relationship
between law and public health and why the two fields need to be better acquainted.
Best Book Read in the Past Year
It is hard to name the best book I've read this past year,
but one that I enjoyed immensely was Never Let Me Go by Kazuo Ishiguro. The book is
dystopian story that seems to be about the dangers of biotechnology, but is, I think, more
generally about the human condition. Of course, that is my broader take on many issues in
bioethics. They are not difficult because of the novels of technology, they are difficult
because they require us to reconsider enduring dilemmas of the human condition.
Favorite Thing to do When Not at the Law School
Being with my family, but as my children
are no longer little, I find I have less time with them. Walking (when there is no ice!),
reading fiction and following the Red Sox.
To view past faculty profiles, go to http://www.slaw.neu.edu/faculty/facultywords.htm.
[ go to faculty index ]